- Home
- CYRX
CYRX
CryoPort Inc.
as 07-26-2024 4:00pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | BRENTWOOD |
| Market Cap: | 366.0M | IPO Year: | N/A |
| Target Price: | $18.00 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.48 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.32 - $20.11 | Next Earning Date: | 08-07-2024 |
| Revenue: | $225,030,000 | Revenue Growth: | -9.19% |
| Revenue Growth (this year): | 5.92% | Revenue Growth (next year): | 9.67% |
Stock Insider Trading Activity of CryoPort Inc. (CYRX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BERMAN RICHARD J | CYRX | Director | May 15 '24 | Sell | $13.41 | 8,105 | $108,692.91 | 100,000 | SEC Form 4 |
| ZECCHINI EDWARD J | CYRX | Chief Digital and Tech Officer | May 14 '24 | Sell | $13.37 | 3,443 | $46,042.21 | 60,051 | SEC Form 4 |
| SHELTON JERRELL | CYRX | Chief Executive Officer | Mar 25 '24 | Sell | $17.54 | 2,631 | $46,153.79 | 692,182 | SEC Form 4 |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 25 '24 | Sell | $17.54 | 1,079 | $18,928.14 | 128,333 | SEC Form 4 |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 25 '24 | Sell | $17.54 | 1,367 | $23,980.32 | 77,444 | SEC Form 4 |
| Mandalam Ramkumar | CYRX | Director | Mar 15 '24 | Sell | $14.68 | 3,217 | $47,225.56 | 43,187 | SEC Form 4 |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 9 '24 | Sell | $15.43 | 1,035 | $15,972.33 | 123,662 | SEC Form 4 |
| STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Mar 9 '24 | Sell | $16.35 | 1,119 | $18,298.34 | 124,697 | SEC Form 4 |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 9 '24 | Sell | $16.35 | 1,418 | $23,187.70 | 74,373 | SEC Form 4 |
| Sawicki Mark W | CYRX | Chief Scientific Officer | Mar 9 '24 | Sell | $15.43 | 1,312 | $20,247.05 | 73,061 | SEC Form 4 |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '24 | Sell | $16.35 | 3,723 | $60,879.99 | 636,951 | SEC Form 4 |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '24 | Sell | $20.79 | 2,599 | $54,030.61 | 634,352 | SEC Form 4 |
| SHELTON JERRELL | CYRX | President, CEO | Mar 9 '24 | Sell | $15.04 | 54,440 | $818,853.82 | 694,813 | SEC Form 4 |
| Hariri Robert J | CYRX | Director | Dec 14 '23 | Sell | $16.89 | 800 | $13,512.00 | 12,716 | SEC Form 4 |
| Hariri Robert J | CYRX | Director | Dec 11 '23 | Sell | $15.50 | 1,000 | $15,500.00 | 13,516 | SEC Form 4 |
Latest CryoPort Inc. News
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
PR Newswire
4 days ago
Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024
Zacks
15 days ago
CryoPort (CYRX) Moves 26.7% Higher: Will This Strength Last?
Zacks
17 days ago
CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
PR Newswire
a month ago
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend
Simply Wall St.
2 months ago
Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?
Simply Wall St.
2 months ago
Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks
Compare CYRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.